Mitochondrial complex IV defects induce metabolic and signaling perturbations that expose potential vulnerabilities in HCT116 cells
Mutations in genes encoding cytochrome c oxidase (mitochondrial complex IV) subunits and assembly factors [e.g., synthesis of cytochrome c oxidase 2 (SCO2)] are linked to severe metabolic syndromes. Notwithstanding that SCO2 is under transcriptional control of tumor suppressor p53, the role of mitoc...
Main Authors: | Oro Uchenunu, Alexander V. Zhdanov, Phillipe Hutton, Predrag Jovanovic, Ye Wang, Dmitry E. Andreev, Laura Hulea, David J. Papadopoli, Daina Avizonis, Pavel V. Baranov, Michael N. Pollak, Dmitri B. Papkovsky, Ivan Topisirovic |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-05-01
|
Series: | FEBS Open Bio |
Subjects: | |
Online Access: | https://doi.org/10.1002/2211-5463.13398 |
Similar Items
-
Metformin revert insulin‐induced oxaliplatin resistance by activating mitochondrial apoptosis pathway in human colon cancer HCT116 cells
by: Chao Liu, et al.
Published: (2020-06-01) -
Control of protein translation by IP3R-mediated Ca2+ release in Drosophila neuroendocrine cells
by: Megha, et al.
Published: (2017-10-01) -
Metformin extends C. elegans lifespan through lysosomal pathway
by: Jie Chen, et al.
Published: (2017-10-01) -
AMPK: Regulation of Metabolic Dynamics in the Context of Autophagy
by: Isaac Tamargo-Gómez, et al.
Published: (2018-11-01) -
Insight on Transcriptional Regulation of the Energy Sensing AMPK and Biosynthetic mTOR Pathway Genes
by: Abitha Sukumaran, et al.
Published: (2020-07-01)